TY  - JOUR 
AU  - Calar, Kristin
AU  - Plesselova, Simona
PY  - 2020
UR  - http://hdl.handle.net/10481/63373
AB  - Lack of efficacy and a low overall success rate of phase I-II clinical trials are the most
common failures when it comes to advancing cancer treatment. Current drug sensitivity screenings
present several challenges including differences in cell...
LA  - eng
PB  - MDPI
KW  - 3D culture
KW  - Breast cancer
KW  - Treatment response
KW  - Precision medicine
KW  - Drug metrics
TI  - Human Plasma-Derived 3D Cultures Model Breast Cancer Treatment Responses and Predict Clinically Effective Drug Treatment Concentrations
DO  - 10.3390/cancers12071722
ER  -